A detailed history of Grey Street Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Grey Street Capital, LLC holds 15,348 shares of ABT stock, worth $1.75 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
15,348
Previous 4,340 253.64%
Holding current value
$1.75 Million
Previous $478 Million 265.18%
% of portfolio
0.24%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 09, 2024

BUY
$109.52 - $120.96 $1.21 Million - $1.33 Million
11,008 Added 253.64%
15,348 $1.74 Billion
Q4 2023

Jan 11, 2024

BUY
$90.19 - $110.4 $3,156 - $3,864
35 Added 0.81%
4,340 $478 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $416,982 - $490,813
4,305 New
4,305 $436 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Grey Street Capital, LLC Portfolio

Follow Grey Street Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Street Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Street Capital, LLC with notifications on news.